Commercial Business Growth
Commercial represented ~10% of total revenue and grew over 15% for the year, driven by the Summit Edge blender and a successful Sunkist-branded commercial product agreement launched in Q2 that exceeded expectations.
Hamilton Beach Health Reached Profitability and Rapid Subscription Growth
Health achieved positive operating profit in Q3 and again in Q4 (within 18 months of acquisition), grew its patient subscription base by ~50% in 2025, expanded specialty pharmacy partnerships (including Synerwell and Lumicera), and launched HealthBeacon Harmony with Novartis.
Reduced Tariff Exposure via Manufacturing Diversification
Company built supply-chain flexibility across APAC (China, Vietnam, Thailand, Indonesia) allowing production shifts by economics and reducing tariff risk exposure following the 2025 tariff disruptions.
Meaningful Shareholder Returns
Returned capital through repurchases (~507,000 shares for ~$9M) and dividends ($6.4M), representing the return of more than 58% of 2025 net income to shareholders.
Positive Outlook and Strategic Investment for 2026 Growth
Management expects mid-single-digit revenue growth in 2026 despite a ~$22M Bartesian license headwind, anticipates gross margins similar to or slightly better than 2025, plans increased advertising (more than the past 4 years combined), and forecasts operating cash flow less investing of $35M–$45M for 2026.
Quarterly Revenue Stabilization
Q4 revenue of $212.9M was nearly flat versus prior-year $213.5M (down ~0.3% / 30 bps), marking a sharp sequential recovery from earlier declines (sales down ~18% in Q2 and ~15% in Q3) and signaling stabilization heading into 2026.
Gross Margin and Q4 Profit Expansion
Q4 gross profit rose to $60.2M, up 8% YoY, with gross margin improving to 28.3% from 26.1% (+220 bps YoY and ~+700 bps vs Q3); fourth-quarter operating profit increased 8% to $25.4M and operating margin expanded to 11.9% (+90 bps).
Adjusted Full-Year Operating Profit Improved Excluding One-Times
Full-year reported operating profit was $36.6M (6.0% of sales), but excluding $5.3M of one-time incremental tariffs and $1.6M ERP accelerated depreciation/write-off, adjusted operating profit rose to $43.5M (7.2% of sales), indicating core operating resiliency.
Premium Lotus Brand Launch Outperformed
The newly launched Lotus premium line delivered sell-through 'strong double digits' ahead of expectations, prompting a key retailer to commit increased shelf space; Lotus is supported by a $6M marketing plan over 15 months (with $2M spent in 2025).